UUID:”MAME-D1EB-4342-B2AD-64F2513R45e4F2
TCGA- YL- -A9IIIX- -91A- PR

||||||||||||Il||IIIIIIIIII||I||I||||l||||MIMI||I||

 

IIII
IIII IIIIIIIIIIIIIIIIIIIIIIIII
III II
PROSTATE AND PELVIC/OBTURATOR LYMPH NODES; RADIC__AL PROSTATECTOMY:
TUMOR PROCUREMENT:
HISTOLOGIC TYPE

ACINAR ADENOCARCINOMA

HISTOLOGIC GRADE (PRIMARY PA'I‘I'ERN+SECONDARY PATTERN = GLEASON SCORE):

4 + 5 = 9
TERTIARY PATTERN 3
PERCENTAGE OF DIFFERENT GLEASON PATTERNS
NOT REPORTED
TUMOR LOCATION
ANTERIOR
RIGHT
LEFT
POSTERIOR
RIGHT
LEFT
EXTRA-PROSTATIC EXTENSION
PRESENT
NON-FOCAL
SITE OF EXTRA-PROSTATIC EXTENSION
POSTERIOR
RIGHT
LEFT
SEMINAL VESICAL INVASION
PRESENT
BOTH
SURGICAL MARGINS
INVOLVED BY INVASIVE CARCINOMA
POSTERIOR
RIGHT
LEFT
NATURE OFPOSITIVE MARGINS
INDETERMINATE
EXTENT OF POSITIVE MARGINS
MULTIFOCAL
MILLIMEI'RIC EXTENT OF POSITIVE MARGINS: _NOT REPORTED
GLEASON GRADE OF CARCINOMA PRESENT AT THE POSITIVE MARGINS
NOT REPORTED
LYMPHOVASCULAR INVASION
PRESENT
PERINEURAL INVASION
PRESENT
TUMOR VOLUME
PROPORTION OF PROSTATE INVOLVED BY CARCINOMA. _25%
TREATMENT EFFECT ON CARCINOMA
NOT APPLICABLE
LYMPH NODES
RIGHT OBTURATOR
NUMBER OF NODES INDENTIFIED: _2_
NUMBER OF NODES INVOLVED BY METASTASIS: _0__
LEFT OBTURATOR
NUMBER OF NODES IDENTIFIED: _9_
NUMBER OF NODES INVOLVED BY METASTASIS: _1_
DIAMETER OF LARGEST LYMPH NODE METASTASIS: _NOT REPORTED

ICED we) ‘ 3

amwwwmkws g/ 4015

6:12.: W N53 lel,°(

9A: 5/[9/1’4

ADDITIONAL PATHOLOGIC FINDINGS
NONE
PATHOLOGICAL STAGING
pT3b
pN1
pMX

HIPAA Discre :ncv

Pvio! Malignancy History
.4 u -
Iv

Dual/Synchronous Vrimn - A -
. . .

 

 

 

 

 

TCGA Pathologlc Diagnosis Discrepancy Form

 

 

 

 

Case Quality Control Form completed for the submitted case.

W The TCGA Pathologic Diagnosis Diserepancy Form should be completed when the pathologic diagnosis
documented on the initial pathology report for a case submitted for TCGA is Inconsistent with the diagnosis provided on the

 

 

 

 

 

 

 

Tissue Source Sit’e (TSS): TSS Identiﬁer: . TSS Unique Patient Identifier:
Completed By {Interviewer Name on Opeaé‘lg'nica}: __ Completed Date: I I
[Diagnosis lnformétioh I I _ . _ I ‘ '
It Data Element Entry Alternatives Working Instructions
)1 ' ' Provide the diagnosis] histologic subt'ype(5) documented on
Pat OIogiC DiagnOSis . x I " . the initial pathology report for this case. If the histology for
1 Provided on Initial 4W4“ A! WOW/W4 this case is mlxed. provide all listed subtypes.
Pathology Report 5ft? POL.) 4,5,: t; ‘
‘ Tammy d
. . Provide the histologic features selecoad on the TCGA Case
gzt‘ggglfefejgﬁzsegf . )L} _ A ‘ LC/WCM/tﬁ Quality Control Form umpietued I'orthis case.
2 for TCGX agreﬂecred \ I w. ¢ I I
éttWS‘c’A] 5’4 T" /

on the CQCF.

 

 

[Discrepancy between Pathology Report and Case Quality Control Form

 

 

3 Provide the reason for
the discrepancy

between the pathology Fmeai 3L5“ £61171 ‘7?! 25/}
report and the TCGA v

Case Quality Control 5/15” L152) #04112: 547% ‘5'“
Form.

W await/e"

Provide a reason describing why the diagnosis on the initiaI
pathology report for this case is not mnslstent with the
diagnosis selected on the TCGA Case Quality Control Form.

 

Name of’l‘SS Reviewing
4 Pathologist or
Biorepository Director

 

 

 

 

 

Provide the name of the pathologist who reviewed this case
{or‘l‘CGA

 

I acknowledge that the above tnfonnadou provided by my institution is we and-correct and has been quality controlled

 

TSS Reviewing Pathologist or Biorepository Director

J acknowledge that the above information provided by my institution is true and-correct and has been quality coho-oiled. The Attending Pathologist or the

Date

Department malt-man has been informed or is aware oftbe above discrepancy In diagnoses.

 

 

Pﬁncipal Investigator SignatiEe

Date

 

 

 

 

 

